Mechanism and function of autosomal analog of X inactivation

X失活常染色体类似物的机制和功能

基本信息

  • 批准号:
    8755040
  • 负责人:
  • 金额:
    $ 89.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-30 至 2019-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Autosomal monoallelic expression (MAE) is a recently discovered epigenetic phenomenon that controls the relative expression of maternal and paternal alleles in more than 10% of mammalian genes. The way the active allele is randomly chosen and then stably maintained due to MAE closely resembles X chromosome inactivation, though MAE affects genes in both male and female cells. When the two alleles are functionally distinct, MAE can profoundly affect cell fate, causing two sister cells within the sam individual to perform in diametrically opposite ways, depending on whether the normal or mutant allele of the gene is active. Understanding the function and mechanism of MAE should significantly contribute to revealing the precise link between specific gene variants and susceptibility to a variety of disorders. Genes subject to MAE are implicated in major diseases including cancer, autism, and Alzheimer's disease, promising that MAE research will have a significant impact on multiple fields of biomedicine. However, progress in understanding mechanistic and functional aspects of MAE has been hindered by the inadequacy of traditional technological approaches, which don't allow for systematic analysis of a mechanism that inherently generates enormous cell-to-cell variation. This epigenetic heterogeneity masks variation in allelic expression in contexts where cells are analyzed in bulk, such as most genome-wide and high-throughput research strategies. As a result, researchers have lacked basic knowledge or even the tools for efficiently generating this knowledge. In response, we have developed and validated several pioneering methods that circumvent this barrier, and enable accurate and precise assessment of MAE in human cells and tissues. Thus, for the first time, we can conduct systematic functional, mechanistic, and genetic studies of MAE. We propose to use and extend several novel technologies to directly address critical questions about MAE biology. We will dissect the molecular mechanisms involved in MAE initiation, development, and stable maintenance over multiple cell divisions in human cells, opening the door to targeted manipulation of allelic activity. We also propose to answer the following fundamental functional questions about effects of MAE: How prevalent is MAE in an organism in vivo? How does it vary between individuals? What are the functional consequences of widespread MAE? Successful completion of this project will provide crucial knowledge for precise interpretation of genotype- phenotype relationship in the context of human normal development and disease. It will also provide new understanding of cell-to-cell and between-individual variability. These insights, as well as knowledge of the mechanisms that control the activity of specific alleles of multiple human genes, may be translated into diagnostic, preventative, and therapeutic treatments in the context of personalized medicine.
描述(由申请人提供):常染色体单相表达(MAE)是一种最近发现的表观遗传现象,可控制超过10%的哺乳动物基因中母体和父亲等位基因的相对表达。尽管MAE与X染色体灭活相似,但随机选择活性等位基因的方式,尽管MAE会影响男性和雌性细胞的基因。当两个等位基因在功能上不同时,MAE会深刻影响细胞的命运,从而导致SAM中的两个姐妹细胞以直径相反的方式进行,具体取决于基因的正常等位基因是活性的。了解MAE的功能和机制应显着促进特定基因变异和与多种疾病的易感性之间的精确联系。 受MAE的基因与包括癌症,自闭症和阿尔茨海默氏病在内的主要疾病有关,承诺MAE研究将对多个生物医学领域产生重大影响。但是,传统技术方法不足,理解MAE的机理和功能方面的进展受到了阻碍,这种方法不允许对固有产生巨大细胞间变化的机制进行系统分析。这种表观遗传异质性掩盖了在批量分析细胞(例如大多数全基因组和高通量研究策略)中,等位基因表达的变化。结果,研究人员缺乏基本知识,甚至缺乏有效产生这种知识的工具。 作为回应,我们开发了并验证了几种绕过这种障碍的开创性方法,并能够准确,准确地评估人类细胞和组织中的MAE。因此,我们第一次可以对MAE进行系统的功能,机械和遗传研究。 我们建议使用并扩展几种新型技术,以直接解决有关MAE生物学的关键问题。我们将剖析人类细胞中多个细胞分裂的MAE启动,发育和稳定维护所涉及的分子机制,从而打开了针对性的等位基因活性操纵的大门。我们还建议回答有关MAE影响的以下基本功能问题:MAE在体内有多流行?个人之间有何不同?广泛的MAE有什么功能后果? 该项目的成功完成将提供至关重要的知识,以在人类正常发育和疾病的背景下精确解释基因型表型关系。它还将提供对细胞间和个体之间的新理解。这些见解以及对控制多个人类基因特定等位基因活动的机制的了解,可以在个性化医学的背景下转化为诊断,预防和治疗性治疗。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Alexander Gimelbrant其他文献

Alexander Gimelbrant的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Alexander Gimelbrant', 18)}}的其他基金

(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
(PQD4) 表观遗传杂合性丧失是癌症场效应的驱动因素
  • 批准号:
    8839747
  • 财政年份:
    2014
  • 资助金额:
    $ 89.53万
  • 项目类别:
(PQD4) Epigenetic loss of heterozygosity as a driver of the cancer field effect
(PQD4) 表观遗传杂合性丧失是癌症场效应的驱动因素
  • 批准号:
    8686513
  • 财政年份:
    2014
  • 资助金额:
    $ 89.53万
  • 项目类别:
Epigenetic loss of heterozygosity in a recurrent neurodevelopmental CNV region
复发性神经发育 CNV 区域杂合性的表观遗传丧失
  • 批准号:
    8806270
  • 财政年份:
    2014
  • 资助金额:
    $ 89.53万
  • 项目类别:
Mechanism and function of autosomal analog of X inactivation
X失活常染色体类似物的机制和功能
  • 批准号:
    9334893
  • 财政年份:
    2014
  • 资助金额:
    $ 89.53万
  • 项目类别:
Assessing parent-of-origin transcriptional effects in Xenopus laevis
评估非洲爪蟾的亲本转录效应
  • 批准号:
    8911356
  • 财政年份:
    2014
  • 资助金额:
    $ 89.53万
  • 项目类别:
Epigenetic loss of heterozygosity in a recurrent neurodevelopmental CNV region
复发性神经发育 CNV 区域杂合性的表观遗传丧失
  • 批准号:
    8922061
  • 财政年份:
    2014
  • 资助金额:
    $ 89.53万
  • 项目类别:
Mechanism and function of autosomal analog of X inactivation
X失活常染色体类似物的机制和功能
  • 批准号:
    8929259
  • 财政年份:
    2014
  • 资助金额:
    $ 89.53万
  • 项目类别:

相似国自然基金

时空序列驱动的神经形态视觉目标识别算法研究
  • 批准号:
    61906126
  • 批准年份:
    2019
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
  • 批准号:
    41901325
  • 批准年份:
    2019
  • 资助金额:
    22.0 万元
  • 项目类别:
    青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
  • 批准号:
    61802133
  • 批准年份:
    2018
  • 资助金额:
    23.0 万元
  • 项目类别:
    青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
  • 批准号:
    61872252
  • 批准年份:
    2018
  • 资助金额:
    64.0 万元
  • 项目类别:
    面上项目
针对内存攻击对象的内存安全防御技术研究
  • 批准号:
    61802432
  • 批准年份:
    2018
  • 资助金额:
    25.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
  • 批准号:
    10822202
  • 财政年份:
    2024
  • 资助金额:
    $ 89.53万
  • 项目类别:
Differences in Hospital Nursing Resources among Black-Serving Hospitals as a Driver of Patient Outcomes Disparities
黑人服务医院之间医院护理资源的差异是患者结果差异的驱动因素
  • 批准号:
    10633905
  • 财政年份:
    2023
  • 资助金额:
    $ 89.53万
  • 项目类别:
Competitive Bidding in Medicare and the Implications for Home Oxygen Therapy in COPD
医疗保险竞争性招标以及对慢性阻塞性肺病家庭氧疗的影响
  • 批准号:
    10641360
  • 财政年份:
    2023
  • 资助金额:
    $ 89.53万
  • 项目类别:
Alzheimer's Disease and Related Dementia-like Sequelae of SARS-CoV-2 Infection: Virus-Host Interactome, Neuropathobiology, and Drug Repurposing
阿尔茨海默病和 SARS-CoV-2 感染的相关痴呆样后遗症:病毒-宿主相互作用组、神经病理生物学和药物再利用
  • 批准号:
    10661931
  • 财政年份:
    2023
  • 资助金额:
    $ 89.53万
  • 项目类别:
NeuroMAP Phase II - Recruitment and Assessment Core
NeuroMAP 第二阶段 - 招募和评估核心
  • 批准号:
    10711136
  • 财政年份:
    2023
  • 资助金额:
    $ 89.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了